Evotec SE
EVO
ISIN US30050E1055 / Valor 3979578
Evotec SE
UMushroom community rating:
About company
Evotec SE is a global platform company focused on discovering and developing highly effective therapeutics in various therapeutic areas such as neurology, oncology, metabolic, and infectious diseases. The company leverages its data-driven multimodality platform and innovative technologies to create a world-leading pipeline of proprietary and co-owned R&D projects. With strategic partnerships with top pharmaceutical companies, biotechnology firms, academic institutions, and other healthcare stakeholders, Evotec aims to make its pharmaceutical products globally available to patients in need. Operating globally with over 5,000 employees across 17 sites in six countries, Evotec is committed to accelerating innovations and creating strategic collaborations to advance drug discovery projects and assets.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
1882 M
Market cap (USD)
17,698
Daily traded volume (Shares)
5.36 / 5.17
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
